2 weeks Ago By ABMN Staff
GE HealthCare Technologies Inc. ( NASDAQ:GEHC – Get Free Report )’s stock price hit a new 52-week high during trading on Friday . The stock traded as high as $94.
55 and last traded at $94.27, with a volume of 1037798 shares. The stock had previously closed at $92.
49. Analysts Set New Price Targets A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co.
initiated coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price for the company.
UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their target price for the company from $84.00 to $74.00 in a research note on Thursday.
Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a research report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target on the stock.
Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Finally, BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th.
One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $93.92.
View Our Latest Stock Analysis on GEHC GE HealthCare Technologies Trading Down 0.5 % GE HealthCare Technologies ( NASDAQ:GEHC – Get Free Report ) last released its earnings results on Wednesday, July 31st. The company reported $1.
00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02.
The company had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion.
GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%.
The company’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.
92 earnings per share. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.
26 EPS for the current year. GE HealthCare Technologies Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.
03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.
12 annualized dividend and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.
51%. Insider Activity In related news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th.
The shares were sold at an average price of $80.78, for a total transaction of $222,145.00.
Following the completion of the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website .
0.27% of the stock is owned by corporate insiders. Hedge Funds Weigh In On GE HealthCare Technologies A number of hedge funds have recently modified their holdings of GEHC.
Vanguard Group Inc. increased its position in GE HealthCare Technologies by 9.2% in the 1st quarter.
Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after purchasing an additional 4,107,746 shares during the last quarter. Capital Research Global Investors increased its holdings in GE HealthCare Technologies by 5.
2% in the first quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock worth $4,908,406,000 after buying an additional 2,647,204 shares during the last quarter. Perpetual Ltd bought a new position in GE HealthCare Technologies during the first quarter valued at approximately $96,135,000.
Marshall Wace LLP acquired a new stake in GE HealthCare Technologies in the second quarter valued at approximately $63,639,000. Finally, Jacobs Levy Equity Management Inc. grew its position in GE HealthCare Technologies by 4,959.
8% in the first quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock worth $68,957,000 after acquiring an additional 743,523 shares in the last quarter.
82.06% of the stock is owned by institutional investors and hedge funds. GE HealthCare Technologies Company Profile ( Get Free Report ) GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. Read More Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter .
.
